Boehringer Ingelheim News Releases
See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.
News Archive
19.11.2008
Winners announced for 2008 Eloquium Award
17.11.2008
First pivotal trials begin for Boehringer Ingelheim’s novel triple angiokinase inhibitor Vargatef™ (BIBF 1120)
For medical media, outside the US only
11.11.2008
Longest follow-up period for any new oral anticoagulant explores Pradaxa® (dabigatran etexilate) for stroke prevention in atrial fibrillation (AF)
For medical media, outside the US only
31.10.2008
Largest study of its kind reveals low sexual desire is most common female sexual problem
For medical media, outside the US only
30.10.2008
Closing in on the cause of diabetes
Diabetes researcher Markus Stoffel is awarded the prestigous Heinrich Wieland Prize – Nepomuk Zöllner receives the Heinrich Wieland Medal for his lifetime achievement in gout research 24.10.2008 European CHMP adopts negative opinion on Cymbalta for the treatment of fibromyalgia For medical media, outside the US only 23.10.2008 Telmisartan (Micardis®) as effective as ramipril but with better long-term tolerability in high-risk cardiovascular Asian patients For medical media, outside the US only 22.10.2008 From Curiosity to Discovery:
Boehringer Ingelheim broadens oncology pipeline with promising new data for potentially first in class Plk1 inhibitor For medical media, outside the US only 17.10.2008 From Curiosity to Discovery:
Boehringer Ingelheim’s pipeline update unveils novel investigational compounds heralding the Company’s entry into Type 2 Diabetes
06.10.2008 ERS COPD Research Award 2008 sponsored by Boehringer Ingelheim
Diabetes researcher Markus Stoffel is awarded the prestigous Heinrich Wieland Prize – Nepomuk Zöllner receives the Heinrich Wieland Medal for his lifetime achievement in gout research 24.10.2008 European CHMP adopts negative opinion on Cymbalta for the treatment of fibromyalgia For medical media, outside the US only 23.10.2008 Telmisartan (Micardis®) as effective as ramipril but with better long-term tolerability in high-risk cardiovascular Asian patients For medical media, outside the US only 22.10.2008 From Curiosity to Discovery:
Boehringer Ingelheim broadens oncology pipeline with promising new data for potentially first in class Plk1 inhibitor For medical media, outside the US only 17.10.2008 From Curiosity to Discovery:
Boehringer Ingelheim’s pipeline update unveils novel investigational compounds heralding the Company’s entry into Type 2 Diabetes
06.10.2008 ERS COPD Research Award 2008 sponsored by Boehringer Ingelheim

